Delivery Order SPE2DB20D3101-SPE2DB22FH7X7
- Not listed
- This federal contract award, valued at $8,208.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,568,077,879 units of Potassium Chloride Extended Release 20 MEQ Tablets in 500-count bottles. The contract has a period of performance through April 30, 2025 and is a firm fixed-price arrangement. Amerisourcebergen Drug Corp is the prime contractor, and...
- This federal contract award, with ID SPE2DB20D3103|SPE2DB23FN9W1, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,033.75 firm fixed-price delivery order is for the supply of Potassium Chloride Extended-Release 8 MEQ Tablets in 500-count packages. The award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
- The federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract, valued at $1,017.85, is a delivery order awarded by the Defense Logistics Agency (DLA) to provide potassium chloride extended-release tablets. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC serves...
- This federal contract award, valued at $2,876.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Potassium Chloride Extended Release 8 MEQ tablets in quantities of 500 per bottle. The contract is a Firm Fixed Price Delivery Order, with a period of performance running through March 4, 2025. No set-aside designation was used for this award. Amerisourcebergen...
- This is a firm-fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of a medication, Potassium Chloride Extended Release 20 MEQ Tablet, and has a ceiling value of $8,528.61. The contract does not have a set-aside designation, indicating it was open to full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,485.18 firm-fixed-price contract is for the delivery of 4,564,388,091 potassium chloride extended-release 20 milliequivalent tablets. The contract is not set aside for any specific business category. It is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support...
- This federal contract award, SPE2DX15D3306|SPE2DX23FADBC, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,045.00 firm fixed-price delivery order is for the supply of Potassium Chloride ER 8 MEQ Tablet, 500 tablets. The award has an ultimate completion date of September 19, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation. The $2,415.40 firm fixed-price delivery order is for the supply of 4565837047 - Potassium Chloride Extended Release 20 MEQ Tablets, in 500-count bottles. The award has an ultimate completion date of September 18, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,687.38 firm fixed price contract is for the delivery of 500 units of Potassium Chloride Extended Release 20 MEQ Tablets, a generic medication used to treat potassium deficiencies. The award is not associated with a specific set-aside program, indicating open competition. Amerisourcebergen holds...
- This federal contract award is for the delivery of 500 tablets of Potassium Chloride Extended Release 20 MEQ tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 23, 2022, with a ceiling value of $2,824.76. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora,...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB22FH7X7Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Potassium Chloride Extended Release 8 MEQ Tablets in 500-count bottles. The $1,235.51 firm-fixed price delivery order was placed under an Indefinite Delivery Contract (IDC) with Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00. This IDC serves as the primary vehicle for Cencora, Inc. to supply a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities and veterans' healthcare programs worldwide. The contract did not have a set-aside designation, indicating full and open competition. Amerisourcebergen, as a key vendor for federal healthcare programs, fulfills critical medical commodity needs across various therapeutic areas for the Department of Defense and other government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 2/10/22 |